STAT

Sexual harassment allegations against Sam Isaly ripple through finance world

A high-value client of Sam Isaly's firm, OrbiMed, is reviewing its relationship with the fund in the wake of sexual harassment allegations first published in STAT.

As sexual harassment allegations against hedge fund titan Sam Isaly echo around Wall Street, one of his firm’s multibillion-dollar clients is reviewing its relationship with the fund, and Isaly has been removed from the agenda of an upcoming investor conference.

Isaly, the 72-year-old founder and managing partner of OrbiMed Advisors, for years sexually harassed and demeaned female employees, six former OrbiMed employees have told STAT. Isaly has denied the allegations.

Eaton Vance, an investment firm with more than $400 billion on Tuesday evening. The firm pays OrbiMed for investment advice.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks